GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Progressive Care Inc (OTCPK:RXMD) » Definitions » Debt-to-EBITDA

RXMD (Progressive Care) Debt-to-EBITDA : -0.05 (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Progressive Care Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Progressive Care's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $0.35 Mil. Progressive Care's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $1.17 Mil. Progressive Care's annualized EBITDA for the quarter that ended in Jun. 2024 was $-33.89 Mil. Progressive Care's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 was -0.04.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Progressive Care's Debt-to-EBITDA or its related term are showing as below:

RXMD' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -14.6   Med: 0.04   Max: 4.31
Current: -0.07

During the past 13 years, the highest Debt-to-EBITDA Ratio of Progressive Care was 4.31. The lowest was -14.60. And the median was 0.04.

RXMD's Debt-to-EBITDA is ranked worse than
100% of 445 companies
in the Healthcare Providers & Services industry
Industry Median: 2.39 vs RXMD: -0.07

Progressive Care Debt-to-EBITDA Historical Data

The historical data trend for Progressive Care's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progressive Care Debt-to-EBITDA Chart

Progressive Care Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.09 4.31 1.84 -0.64 N/A

Progressive Care Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.71 -0.03 0.86 -0.05

Competitive Comparison of Progressive Care's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Progressive Care's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Progressive Care's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Progressive Care's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Progressive Care's Debt-to-EBITDA falls into.



Progressive Care Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Progressive Care's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.333 + 1.329) / N/A
=N/A

Progressive Care's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.348 + 1.169) / -33.892
=-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2024) EBITDA data.


Progressive Care  (OTCPK:RXMD) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Progressive Care Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Progressive Care's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Progressive Care Business Description

Traded in Other Exchanges
N/A
Address
400 Ansin Boulevard, Suite A, Hallandale Beach, FL, USA, 33009
Progressive Care Inc is a personalized healthcare services and technology company that provides prescription pharmaceutical services, risk management, and data analytics to healthcare organizations and providers. The company through its wholly-owned subsidiary Pharmco, provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, and health practice risk management. It also offers certain disease testing and vaccinations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian, and Russian.
Executives
Charles M. Fernandez director, 10 percent owner, officer: Chairman & CEO C/O FAIRHOLME CAPITAL MANAGEMENT, L.L.C., 4400 BISCAYNE BOULEVARD, 9TH FLOOR, MIAMI FL 33137
Rodney Barreto director, 10 percent owner 460 MARQUESA DRIVE, CORAL GABLES FL 33156
Pamela M Roberts officer: CHIEF OPERATING OFFICER 1540 NW 203 ST, MIAMI FL 33169
Pedro Rodriguez director 258 NE 27TH STREET, MIAMI FL 33137
Birute Norkute officer: Chief Operating Officer 2311 NE 174TH ST, MIAMI FL 33160
Alan Jay Weisberg officer: CHIEF FINANCIAL OFFICER 2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431
Cecile Munnik officer: CFO 400 ANSIN BLVD SUITE A, HALLANDALE BEACH FL 33009
Joseph Ziegler director 1051 HILLSBORO MILE, PH2, HILLSBORO BEACH FL 33062
Jervis Hough director 6053 BARTAM COVE, DULUTH GA 30097
Shital P Parikh director, officer: Chief Operating Officer 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169
Vernon Watson officer: Chief Executive Officer 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169
Armen Karapetyan 10 percent owner 17395 NORTH BAY ROAD, SUITE 102, SUNNY ISLES BEACH FL 33160
Avraham A. Friedman director, 10 percent owner, officer: Chief Executive Officer C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162
Andy Subachan director, 10 percent owner, officer: Chief Operating Officer C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162
Buddy Young director, 10 percent owner, officer: President, CEO, CFO, Chairman

Progressive Care Headlines